BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2718234)

  • 1. Stability of platelet and plasma HLA concentrations in healthy adults or random-donor platelet concentrates.
    Kao KJ
    Transfusion; 1989 May; 29(4):328-31. PubMed ID: 2718234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets.
    Levy L; Woodfield DG
    N Z Med J; 1984 Oct; 97(766):719-21. PubMed ID: 6595558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma and platelet HLA in normal individuals: quantitation by competitive enzyme-linked immunoassay.
    Kao KJ
    Blood; 1987 Jul; 70(1):282-6. PubMed ID: 3593967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experience of HLA-matched platelet transfusion in patients who are refractory to random donor platelets].
    Sekiguchi S; Mitani T; Ohnuma M; Katoh T; Ikeda H; Nakase T; Morioka M; Sakurada K; Miyazaki T
    Hokkaido Igaku Zasshi; 1988 Jul; 63(4):552-61. PubMed ID: 3220437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelets do not adsorb HLA class I molecules during storage of pooled platelet concentrates.
    Zeiler T; Heim M; Dempfle A; Kretschmer V
    Transfus Med; 2006 Jun; 16(3):176-83. PubMed ID: 16764596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of histocompatible apheresis platelet donors by cross-matching random donor platelet concentrates.
    O'Connell BA; Lee EJ; Rothko K; Hussein MA; Schiffer CA
    Blood; 1992 Jan; 79(2):527-31. PubMed ID: 1730095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between donor-recipient lymphocytotoxicity and the transfusion response using HLA-matched platelet concentrates.
    Herzig RH; Terasaki PI; Trapani RJ; Herzig GP; Graw RG
    Transfusion; 1977; 17(6):657-61. PubMed ID: 595123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet crossmatch testing for donor selection.
    Slichter SJ
    Prog Clin Biol Res; 1982; 88():153-64. PubMed ID: 7100207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of in vitro assays in selection of compatible platelet donors.
    Tosato G; Appelbaum FR; Trapani RJ; Dowling R; Deisseroth AB
    Transfusion; 1980; 20(1):47-54. PubMed ID: 7355471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of an appropriate size of unrelated donor pool to be registered for HLA-matched platelet transfusion.
    Takahashi K; Juji T; Miyazaki H
    Transfusion; 1987; 27(5):394-8. PubMed ID: 3477043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of four methods for platelet compatibility testing.
    McFarland JG; Aster RH
    Blood; 1987 May; 69(5):1425-30. PubMed ID: 3552075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination
    Thuku NW; Shikuku K; Mbugua A
    Pan Afr Med J; 2017; 27():226. PubMed ID: 28979628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of random-donor platelet concentrates prepared from whole blood units and platelets prepared from single-donor apheresis collections.
    Sloand EM; Yu M; Klein HG
    Transfusion; 1996; 36(11-12):955-9. PubMed ID: 8937403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between HLA phenotype and HLA concentration in plasma or platelets.
    Kao KJ; Scornik JC; Riley WJ; McQueen CF
    Hum Immunol; 1988 Feb; 21(2):115-24. PubMed ID: 3284856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of platelet-reactive alloantibodies and evaluation of cross-match-compatible platelets for the management of patients with transfusion refractoriness.
    Wang J; Xia W; Deng J; Xu X; Shao Y; Ding H; Chen Y; Liu J; Chen D; Ye X; Santoso S
    Transfus Med; 2018 Feb; 28(1):40-46. PubMed ID: 28516675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of IL-8 and TNF-alpha in platelet concentrates during storage.
    Shaiegan M; Pourfatollah AA; Namiri M; Babaee G
    Arch Iran Med; 2006 Jan; 9(1):61-4. PubMed ID: 16649381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [HLA and transfusion: new approaches with Luminex™ technology].
    Giannoli C; Nguyen TK; Dubois V
    Transfus Clin Biol; 2011 Apr; 18(2):218-23. PubMed ID: 21397543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLAMatchmaker is effective for selecting appropriate platelet units for alloimmunised thrombocytopaenic patients who are refractory to random donor platelets.
    O'Rafferty C; Rooney G; Hagan R; Woolfson M; O'Donghaile D; Fitzgerald J
    Transfus Med; 2017 Oct; 27 Suppl 5():369-374. PubMed ID: 28393455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective randomized trial of HLA-matched versus mismatched single-donor platelet transfusions in cancer patients.
    Messerschmidt GL; Makuch R; Appelbaum F; Ungerleider RS; Abrams R; O'Donnell J; Holohan TV; Fontana J; Wright D; Anagnou NP
    Cancer; 1988 Aug; 62(4):795-801. PubMed ID: 3293762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement activation during storage of single-donor platelet concentrates.
    Schleuning M; Böck M; Mempel W
    Vox Sang; 1994; 67(2):144-8. PubMed ID: 7801603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.